The Immunohistochemical Assessment of ALDH1 Activity in Breast Cancer and it’s Correlation With Pathologic Features

Background: Aldehyde dehydrogenase 1 (ALDH1) is a marker of normal and malignant human mammary stem cells that has been reported to be associated with poor prognosis. Studies on the detection of ALDH1+ cells can help the treatment of patients with breast cancer. The aim of this study was to determin...

Full description

Bibliographic Details
Main Authors: Molanae S, Kadivar M, Madjd Z, Ramezani B
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2011-12-01
Series:Tehran University Medical Journal
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/19558.pdf&manuscript_id=19558
_version_ 1818057621768241152
author Molanae S
Kadivar M
Madjd Z
Ramezani B
author_facet Molanae S
Kadivar M
Madjd Z
Ramezani B
author_sort Molanae S
collection DOAJ
description Background: Aldehyde dehydrogenase 1 (ALDH1) is a marker of normal and malignant human mammary stem cells that has been reported to be associated with poor prognosis. Studies on the detection of ALDH1+ cells can help the treatment of patients with breast cancer. The aim of this study was to determine the activity of ALDH1 in breast cancer and its relationship with the pathological features of the tumors.Methods: ALDH1 activity was studied by immunohistochemistry in 121 paraffin-embedded histological samples of breast cancer patients from Department of Pathology of Milad Hospital, Tehran, Iran during 2006-2007. The relationship of ALDH1 with the pathological features of the tumors (size, grade, lymph node metastasis and vascular invasion) was also investigated.Results: Eighty-five percent of breast cancer samples expressed ALDH1 in their cytoplasm with a wide range of intensity (weak, moderate and strong), while 18 samples (14.9%) were completely negative. The majority of cases (97.1%) showed ALDH1 positivity in the stroma of tumors which varied from weak (2.9%) to strong (73.5%). ALDH1 H-score (ALDH1% × intensity) of tumor cells varied from 0 to 240 (mean= 80). ALDH1 H-score was ≤80 in 62 (51.2%) and >80 in 59 (48.8%) samples. There was no statistically significant relationship between ALDH1 H-score and age (P=0.358), tumor size (P=0.375), tumor grade (P=0.207), lymph node metastasis (P=0.125) or vascular invasion (P=0.190).Conclusion: ALDH1 activity was demonstrated in 85.1% of breast cancer samples although its level of expression was not correlated with the pathologic features of breast tumors.
first_indexed 2024-12-10T12:47:39Z
format Article
id doaj.art-1a3dbb0a9bb14b6bb0f4e790f421b3aa
institution Directory Open Access Journal
issn 1683-1764
1735-7322
language fas
last_indexed 2024-12-10T12:47:39Z
publishDate 2011-12-01
publisher Tehran University of Medical Sciences
record_format Article
series Tehran University Medical Journal
spelling doaj.art-1a3dbb0a9bb14b6bb0f4e790f421b3aa2022-12-22T01:48:21ZfasTehran University of Medical SciencesTehran University Medical Journal1683-17641735-73222011-12-01699529536The Immunohistochemical Assessment of ALDH1 Activity in Breast Cancer and it’s Correlation With Pathologic FeaturesMolanae SKadivar MMadjd ZRamezani BBackground: Aldehyde dehydrogenase 1 (ALDH1) is a marker of normal and malignant human mammary stem cells that has been reported to be associated with poor prognosis. Studies on the detection of ALDH1+ cells can help the treatment of patients with breast cancer. The aim of this study was to determine the activity of ALDH1 in breast cancer and its relationship with the pathological features of the tumors.Methods: ALDH1 activity was studied by immunohistochemistry in 121 paraffin-embedded histological samples of breast cancer patients from Department of Pathology of Milad Hospital, Tehran, Iran during 2006-2007. The relationship of ALDH1 with the pathological features of the tumors (size, grade, lymph node metastasis and vascular invasion) was also investigated.Results: Eighty-five percent of breast cancer samples expressed ALDH1 in their cytoplasm with a wide range of intensity (weak, moderate and strong), while 18 samples (14.9%) were completely negative. The majority of cases (97.1%) showed ALDH1 positivity in the stroma of tumors which varied from weak (2.9%) to strong (73.5%). ALDH1 H-score (ALDH1% × intensity) of tumor cells varied from 0 to 240 (mean= 80). ALDH1 H-score was ≤80 in 62 (51.2%) and >80 in 59 (48.8%) samples. There was no statistically significant relationship between ALDH1 H-score and age (P=0.358), tumor size (P=0.375), tumor grade (P=0.207), lymph node metastasis (P=0.125) or vascular invasion (P=0.190).Conclusion: ALDH1 activity was demonstrated in 85.1% of breast cancer samples although its level of expression was not correlated with the pathologic features of breast tumors.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/19558.pdf&manuscript_id=19558ALDH1Breast CancerCancer Stem Cells
spellingShingle Molanae S
Kadivar M
Madjd Z
Ramezani B
The Immunohistochemical Assessment of ALDH1 Activity in Breast Cancer and it’s Correlation With Pathologic Features
Tehran University Medical Journal
ALDH1
Breast Cancer
Cancer Stem Cells
title The Immunohistochemical Assessment of ALDH1 Activity in Breast Cancer and it’s Correlation With Pathologic Features
title_full The Immunohistochemical Assessment of ALDH1 Activity in Breast Cancer and it’s Correlation With Pathologic Features
title_fullStr The Immunohistochemical Assessment of ALDH1 Activity in Breast Cancer and it’s Correlation With Pathologic Features
title_full_unstemmed The Immunohistochemical Assessment of ALDH1 Activity in Breast Cancer and it’s Correlation With Pathologic Features
title_short The Immunohistochemical Assessment of ALDH1 Activity in Breast Cancer and it’s Correlation With Pathologic Features
title_sort immunohistochemical assessment of aldh1 activity in breast cancer and it s correlation with pathologic features
topic ALDH1
Breast Cancer
Cancer Stem Cells
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/19558.pdf&manuscript_id=19558
work_keys_str_mv AT molanaes theimmunohistochemicalassessmentofaldh1activityinbreastcanceranditscorrelationwithpathologicfeatures
AT kadivarm theimmunohistochemicalassessmentofaldh1activityinbreastcanceranditscorrelationwithpathologicfeatures
AT madjdz theimmunohistochemicalassessmentofaldh1activityinbreastcanceranditscorrelationwithpathologicfeatures
AT ramezanib theimmunohistochemicalassessmentofaldh1activityinbreastcanceranditscorrelationwithpathologicfeatures
AT molanaes immunohistochemicalassessmentofaldh1activityinbreastcanceranditscorrelationwithpathologicfeatures
AT kadivarm immunohistochemicalassessmentofaldh1activityinbreastcanceranditscorrelationwithpathologicfeatures
AT madjdz immunohistochemicalassessmentofaldh1activityinbreastcanceranditscorrelationwithpathologicfeatures
AT ramezanib immunohistochemicalassessmentofaldh1activityinbreastcanceranditscorrelationwithpathologicfeatures